A 58-year-old man presents with flank pain, hematuria, and a palpable mass in the right flank. On imaging, a 4 cm heterogeneous lesion is seen in the right kidney with areas of necrosis and hemorrhage. Which investigation is most appropriate to confirm the diagnosis and stage the disease?

Explanation

## Investigation of Choice for Renal Cell Carcinoma ### Role of Contrast-Enhanced CT (CECT) **Key Point:** CECT chest, abdomen, and pelvis is the gold standard imaging modality for diagnosis, staging, and assessment of metastatic spread in renal cell carcinoma (RCC). ### Why CECT is Superior 1. **Diagnostic accuracy**: Detects lesions as small as 1–2 cm with high sensitivity (95–100%) and specificity for RCC 2. **Staging information**: Evaluates: - Local invasion into perinephric fat and renal sinus - Renal vein and inferior vena cava (IVC) thrombus - Regional lymph node involvement - Distant metastases (lungs, liver, bones) 3. **Characterization**: Heterogeneous enhancement pattern with areas of necrosis and hemorrhage is classic for RCC 4. **Treatment planning**: Determines surgical candidacy and approach (nephron-sparing vs. radical nephrectomy) ### Imaging Protocol | Phase | Timing | Information | |-------|--------|-------------| | Arterial | 20–30 s | Tumor enhancement, renal artery involvement | | Venous | 70–90 s | Renal vein and IVC thrombus | | Delayed | 3–5 min | Collecting system involvement, metastases | **High-Yield:** The presence of IVC thrombus (detected on CECT) changes staging from T3a to T3b/T3c and influences surgical planning. ### Additional Imaging for Staging - **Chest CT**: Detects pulmonary metastases (present in 10–15% at diagnosis) - **Brain MRI**: Reserved for symptomatic patients or high-risk disease - **Bone scan**: For symptomatic patients or elevated alkaline phosphatase **Clinical Pearl:** Clear cell RCC (most common, ~80%) shows characteristic homogeneous enhancement in arterial phase due to high vascularity; heterogeneous pattern suggests necrosis or higher grade disease. ### Why Biopsy Is Not First-Line - Diagnosis can be made confidently on imaging alone (>95% specificity) - Biopsy carries risk of tumor seeding and hemorrhage - Reserved for indeterminate lesions or when imaging is inconclusive **Mnemonic:** **CECT for RCC** = **C**ontrastenhanced **CT** for **R**enal **C**ell **C**arcinoma — the imaging workhorse.